Cover Story
Conversation with The Cancer LetterFree
A year ago, Fox Chase Cancer Center lost money: $17 million. In 2015, the losses have stopped, and an $8 million operating profit is projected.
In Brief
Drugs & Targets
Trending Stories
- In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- Canine cancers as models: We have barely tapped the full potential of comparative oncology
- Over three years as CEO, Karen Knudsen led ACS through COVID—and reversed the charity’s long slump
- Cold Spring Harbor and Northwell extend collaboration with $150M commitment
- FDA approves Anktiva for non-muscle-invasive bladder cancer